Increased Levels of Circulating Advanced Glycation End-Products in Menopausal Women with Osteoporosis

Abstract

Serum AGEs could be used to monitor the severity and progression of osteoporosis. An increased serum level of AGEs was associated with impaired bone formation and was a risk factor for the development of osteoporosis. Targeting AGEs may represent a novel therapeutic approach for primary or secondary osteoporosis.